Table 1. Participant characteristics and baseline and final biomarkers for low inflammatory and high inflammatory groups.

	Low inflammatory group (CRP < 3)					High inflammatory group (CRP ≥ 3)
		Baseline	Final	Effect Size, Cohen’s d	P		Baseline	Final	Effect Size, Cohen’s d	P
	N	mean	mean			N	mean	mean
Age, yrs	23	53 ± 1.4				14	51.5 ± 1.7
Height, cm	22	167 ± 1.3				14	166.4 ± 1.2
Weight, kg	22	82.4 ± 3.8	79.8 ± 3.4a	.58	.62	14	90.6 ± 4.8	90.1 ± 4.8	.14	.15
BMI, kg/m²	23	29.4 ± 1.0	28.6 ± 0.9a	.59	.33	14	32.7 ± 1.6	32.3 ± 1.6	.20	.74
Body fat, %	21	39.9 ± 2.1	38.5 ± 1.8	.22	.61	14	43.7 ± 1.3	44.4 ± 1.3	.36	.69
Cholesterol, mg/mL	20	187 ± 5.4	185 ± 5.5	.13	.16	12	193 ± 8.1	188 ± 9.4	.36	.70
Triglycerides, mg/mL	20	87 ± 9.4	70 ± 4.0a	.56	.64	12	75 ± 6.4	65 ± 6.7	.41	.69
HDL, mg/mL	20	66 ± 4.1	65 ± 2.8	.12	.73	12	67 ± 7.6	65 ± 9.1	.16	.78
LDL, mg/mL	20	104 ± 4.5	107 ± 5.0	.24	.70	12	111 ± 7.4	109 ± 7.3	.13	.81
Glucose, mg/mL	20	92 ± 2.7	88 ± 2.6	.41	.69	12	97 ± 1.9	87 ± 2.7a	.84	.65
CRP, mg/L	23	1.3 ± .2	1.8 ± .5	.18	.73	14	6.4 ± .6d	4.4 ± .7b	1.10	.61
SBP, mm Hg	22	121 ± 2.3	119 ± 2.3	.24	.70	14	128 ± 4.0	129 ± 4.3	.10	.83
DBP, mm Hg	22	78 ± 1.4	77 ± 1.7	.24	.70	14	81 ± 2.1	82 ± 2.0	.21	.74
VO2 max, mL/kg/min	23	27.8 ± 1.3	3.5 ± 1.4a	.69	.61	14	23.4 ± 1.0c	25.0 ± 1.4	.45	.67
GFR, mL/1.73m²/min	18	93.3 ± 3.6	98.2 ± 3.5a	.63	.64	12	94.6 ± 5.1	10.7 ± 4.6	.57	.66
CD31+/CD42b- EMPs, events/µL	17	3.7 ± .5	2.2 ± .3a	.71	.64	11	3.6 ± .7	2.1 ± .5	.53	.68
CD62E+ EMPs, events/μL	18	39.2 ± 6.4	24.0 ± 5.5a	.43	.23	10	48.5 ± 9.2	19.7 ± 4.0a	1.35	.66

a. Significantly different (P≤.05) after AEXT vs before AEXT within the same group.

b. Significantly different (P≤.001) after AEXT vs before AEXT within the same group.

c. Significantly different (P≤.05) between groups at the same time point (before or after AEXT).

d. Significantly different (P≤.001) between groups at the same time point (before or after AEXT)

AEXT, aerobic exercise training.